i
Emergency Department Visits and Hospitalizations for Buprenorphine Ingestion by Children — United States, 2010–2011
-
Jan 25 2013
Source: MMWR Morb Mortal Wkly Rep. 2013; 62(3):56.
[PDF-91.63 KB]
Details:
-
Alternative Title:MMWR Morb Mortal Wkly Rep
-
Personal Author:
-
Description:Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to reduce the morbidity and mortality associated with opioid abuse, and buprenorphine has become an increasingly prescribed component of office-based treatment. However, unsupervised ingestion of buprenorphine-containing products by children is a growing concern.
-
Subject:
-
Pubmed ID:23344700
-
Pubmed Central ID:PMC4604875
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
You May Also Like
[JPEG - 331.14 KB]
Email
CDC-INFO
